Atlas Trials

A Study Using Functional Magnetic Resonance Imaging (fMRI) to Assess the Effects of Naltrexone SR/ Bupropion SR Therapy in Overweight or Obese Subjects

Clinical trial NCT00711477 · COMPLETED

Trial details

NCT number
NCT00711477
Sponsor
Orexigen Therapeutics, Inc
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Obesity
Start date
2008-09-01
Primary completion
2010-06-01
Enrollment
46

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.